N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-glucosyl-ß1-1''-sphingosine
|
K025076-50ug
|
99% |
474943-01-6 |
50ug
|
¥ 4088.0
|
4~8周 |
科威 |
N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-lactosyl-ß1-1''-sphingosine
|
K025077-100ug
|
99% |
474943-04-9 |
100ug
|
¥ 7052.0
|
4~8周 |
科威 |
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-lactosyl-ß1-1''-sphingosine
|
K025079-250ug
|
99% |
474943-06-1 |
250ug
|
¥ 15331.0
|
4~8周 |
科威 |
N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-galactosyl-ß1-1''-sphingosine
|
R025294-250ug
|
99% |
170212-26-7 |
250ug
|
¥ 15331.0
|
5~7个工作日 |
罗恩 |
N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-galactosyl-ß1-1''-sphingosine
|
R025294-100ug
|
99% |
170212-26-7 |
100ug
|
¥ 7052.0
|
5~7个工作日 |
罗恩 |
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-galactosyl-ß1-1''-sphingosine
|
R025075-100ug
|
99% |
474942-98-8 |
100ug
|
¥ 7871.0
|
5~7个工作日 |
罗恩 |
3-(4-chloro-5-iodo-7-isopropyl-pyrrolo[2,3-d]pyrimidin-6-yl)propan-1-ol
|
P632747-1g
|
≥97% |
2306277-17-6 |
1g
|
¥ 3841.9
|
期货,请咨询 |
阿拉丁 |
3-(4-chloro-5-iodo-7-isopropyl-pyrrolo[2,3-d]pyrimidin-6-yl)propan-1-ol
|
P632747-100mg
|
≥97% |
2306277-17-6 |
100mg
|
¥ 961.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl 3-oxo-5,6,8,9-tetrahydro-2H-pyridazino[3,4-d]azepine-7-carboxylate
|
T683271-1g
|
≥97% |
1190897-27-8 |
1g
|
¥ 8320.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl 3-oxo-5,6,8,9-tetrahydro-2H-pyridazino[3,4-d]azepine-7-carboxylate
|
T683271-250mg
|
≥97% |
1190897-27-8 |
250mg
|
¥ 3328.9
|
期货,请咨询 |
阿拉丁 |
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-lactosyl-ß1-1''-sphingosine
|
R025079-50ug
|
99% |
474943-06-1 |
50ug
|
¥ 3762.0
|
5~7个工作日 |
罗恩 |
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-galactosyl-ß1-1''-sphingosine
|
R025075-50ug
|
99% |
474942-98-8 |
50ug
|
¥ 4563.0
|
5~7个工作日 |
罗恩 |
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-lactosyl-ß1-1''-sphingosine
|
R025079-100ug
|
99% |
474943-06-1 |
100ug
|
¥ 6487.0
|
5~7个工作日 |
罗恩 |
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-glucosyl-ß1-1''-sphingosine
|
R025076-50ug
|
99% |
474943-01-6 |
50ug
|
¥ 3762.0
|
5~7个工作日 |
罗恩 |
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-glucosyl-ß1-1''-sphingosine
|
R025076-250ug
|
99% |
474943-01-6 |
250ug
|
¥ 14101.0
|
5~7个工作日 |
罗恩 |
N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-lactosyl-ß1-1''-sphingosine
|
R025077-100ug
|
99% |
474943-04-9 |
100ug
|
¥ 6487.0
|
5~7个工作日 |
罗恩 |
N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-galactosyl-ß1-1''-sphingosine
|
K025294-100ug
|
99% |
170212-26-7 |
100ug
|
¥ 7052.0
|
4~8周 |
科威 |
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-glucosyl-ß1-1''-sphingosine
|
K025076-250ug
|
99% |
474943-01-6 |
250ug
|
¥ 15331.0
|
4~8周 |
科威 |
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-glucosyl-ß1-1''-sphingosine
|
K025076-100ug
|
99% |
474943-01-6 |
100ug
|
¥ 7052.0
|
4~8周 |
科威 |
tert-butyl 4-benzyloxy-2-methylsulfanyl-6,8-dihydro-5H-pyrido[3,4-d]pyrimidine-7-carboxylate
|
T681110-5g
|
≥97% |
2648554-48-5 |
5g
|
¥ 23280.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl 4-benzyloxy-2-methylsulfanyl-6,8-dihydro-5H-pyrido[3,4-d]pyrimidine-7-carboxylate
|
T681110-500mg
|
≥97% |
2648554-48-5 |
500mg
|
¥ 5168.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl 4-benzyloxy-2-methylsulfanyl-6,8-dihydro-5H-pyrido[3,4-d]pyrimidine-7-carboxylate
|
T681110-250mg
|
≥97% |
2648554-48-5 |
250mg
|
¥ 3104.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl 4-benzyloxy-2-methylsulfanyl-6,8-dihydro-5H-pyrido[3,4-d]pyrimidine-7-carboxylate
|
T681110-25g
|
≥97% |
2648554-48-5 |
25g
|
¥ 77600.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl 4-benzyloxy-2-methylsulfanyl-6,8-dihydro-5H-pyrido[3,4-d]pyrimidine-7-carboxylate
|
T681110-100mg
|
≥97% |
2648554-48-5 |
100mg
|
¥ 1856.9
|
期货,请咨询 |
阿拉丁 |